Log In | Shopping Cart | Advanced Search
            
  • Home
  • Career
  • Distributors
  • Contact Us:
  • Email: crm@excellgen.com
Products
Modified mRNA
Encapsulated mRNA
mRNA Enzyme
SARS-CoV-2
Pseudovirus
Popular Products
Cancer Proteins
Antibodies
DNA Binding Proteins
Electrophoresis
Genome Engineering
Polymerases
Recombinases
Transcription Factors
Transfection
Comsumbles
Services
Modified mRNA
Custom Cloning
Virus Production
Protein Purification
Protein Expression
Antibodies
 Previous 
 Return to List 
 Next 

Anti-B7-H3 monoclonal antibody, recombinant

Catalog #: EG-372


$250.00

Qty:

EG-372 Anti-B7-H3-C10
Product Name Anti-B7-H3 monoclonal antibody, recombinant
Cat # EG-372
Size 100 µg
Key features Rabbit monoclonal antibody produced in 293 cells with serum-free, protein-free medium, purified with protein A column;
High batch-to-batch consistency and reproducibility;
Long term security of supply;
Clone number C10
Immunogen Recombinant extracellular domain of B7-H3 that was expressed and purified from 293 cells
Reaction target Extracellular region of B7-H3
Species Cross-Reactivity Human
Applications Flow Cytometry; IP; ELISA;
Working concentrations Flow cytometry and ELISA: 5 µg/ml of final concentration is suggested.
IP: 10 μg in 0.3-0.5 mg cell lysates is suggested.
Background B7-H3 (also known as CD276) is a member of B7 family, which is over-expressed in many cancer types. B7-H3 is an immune checkpoint protein that inhibits tumor antigen-specific immune responses. B7-H3 can also promote tumor migration, invasion, angiogenesis, chemoresistance, epithelial-to-mesenchymal transition (EMT), and regulate tumor cell metabolism (Kontos F, et al. B7-H3: an attractive target for antibody-based immunotherapy. Clinical Cancer Research. 2020, 27: 1227–1235). B7-H3 is regarded as an attractive target for cancer immunotherapy. Several anticancer agents are targeting B7-H3, such as enoblituzumab (MGA271), omburtamab, MGD009, MGC018, DS-7300a, and CAR T cells.
QC

Flow cytometry assay showing cell surface expression of B7-H3. KLM-1 cells (10^6) were incubated with 5 μg antibody in 1 ml PBS buffer containing 5% BSA. Antibody binding was detected with Cy5-conjugated goat-anti-rabbit antibody. Blue line, isotype control antibody staining; red line, B7-H3 antibody staining.

Concentration As indicated on the vials
Formulation 80% PBS, pH 7.4; 20% Glycerol; 5% Trehalose; 0.04% Sodium azide as Preservative
Shipping Blue ice
Storage -20 to -70 oC (long term) or 4 oC (one week).
Depending on the expected frequency of use, the product can be aliquoted to avoid heavily repeated freezing/thawing cycles.

     
 Ask a Question 
 
 Home | Privacy Policy | Terms & Conditions | Online Price Policy | Shipping & Return

Copyright © 2007-2023  Excellgen, Inc. All rights reserved